OLBA HEALTHCARE HOLDINGS, Inc.

TSE:2689.T

1962 (JPY) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 118,564.924110,472.64107,959.426112,976.196107,896.793107,428.432107,663.554105,778.686101,460.89694,515.04397,137.87996,223.04474,744.81662,135.92458,863.15854,999.77854,378.491
Cost of Revenue 104,964.1297,518.195,455.447101,376.78896,828.90696,291.50696,640.13394,879.71491,325.20984,756.57687,016.87286,146.94966,848.93855,530.52252,674.08349,016.58948,370.85
Gross Profit 13,600.80412,954.5412,503.97911,599.40811,067.88711,136.92611,023.42110,898.97210,135.6879,758.46710,121.00710,076.0957,895.8786,605.4026,189.0755,983.1896,007.641
Gross Profit Ratio 0.1150.1170.1160.1030.1030.1040.1020.1030.10.1030.1040.1050.1060.1060.1050.1090.11
Reseach & Development Expenses 00000000000000000
General & Administrative Expenses 329366388389396377439523.312529.838509.069481.736482.585447.57398.99401.345415.379420.795
Selling & Marketing Expenses 11,04510,44410,0429,6699,7449,4589,353.5970000000000
SG&A 11,374.1210,81010,43010,05810,1409,8359,792.597523.312529.838509.069481.736482.585447.57398.99401.345415.379420.795
Other Expenses 18.61920.998132.40239.70924.89626.74519.56590.04942.58232.407119.99136.5333.70624.47420.06618.5331.443
Operating Expenses 11,374.1210,803.35610,430.8310,058.64310,140.8559,835.6799,792.5956,208.1255,949.695,534.125,275.0355,147.4664,355.473,686.1333,489.6353,401.6653,361.285
Operating Income 2,226.6842,151.1812,073.1461,540.761927.0271,301.2431,230.8241,044.268543.452668.1941,440.8421,556.11766.766593.162490.115322.805419.218
Operating Income Ratio 0.0190.0190.0190.0140.0090.0120.0110.010.0050.0070.0150.0160.010.010.0080.0060.008
Total Other Income Expenses Net 16.5761263-28-205-120151.042-3,576.451-3,614.733-3,546.621-3,379.129-3,331.396-2,812.879-2,322.117-2,236.676-3,216.241-2,253.996
Income Before Tax 2,243.262,156.5422,136.8211,513.403722.3961,181.7511,381.8681,114.396571.264677.7261,466.8431,597.233727.529597.152462.764-634.717392.36
Income Before Tax Ratio 0.0190.020.020.0130.0070.0110.0130.0110.0060.0070.0150.0170.010.010.008-0.0120.007
Income Tax Expense 742.903742.304601.487524.035481.574445.858338.775432.528265.552272.467650.266653.955381.498284.881238.805145.439255.065
Net Income 1,500.3561,414.2381,535.333989.368326.413775.5821,054.046690.65305.711405.259816.577943.278346.03312.27223.958-780.156137.295
Net Income Ratio 0.0130.0130.0140.0090.0030.0070.010.0070.0030.0040.0080.010.0050.0050.004-0.0140.003
EPS 251.68234.9252.8162.6656.76138.24187.86123.154.4972.23145.54168.1261.6755.6539.91-139.0424.47
EPS Diluted 251.68234.9252.8162.6656.76138.24187.86123.154.4972.23145.54168.1261.6755.6539.91-139.0424.47
EBITDA 2,791.552,684.932,637.9711,966.5041,342.541,692.8371,570.3755,093.7814,626.6034,655.0935,328.355,332.4353,909.5493,213.0172,996.5773,701.7752,937.516
EBITDA Ratio 0.0240.0240.0240.0170.0120.0160.0150.0480.0460.0490.0550.0550.0520.0520.0510.0670.054